Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 4;2023(2):hoad018.
doi: 10.1093/hropen/hoad018. eCollection 2023.

Conventional outcome reporting per IVF cycle/embryo transfer may systematically underestimate chances of success for women undergoing ART: relevant biases in registries, epidemiological studies, and guidelines

Affiliations

Conventional outcome reporting per IVF cycle/embryo transfer may systematically underestimate chances of success for women undergoing ART: relevant biases in registries, epidemiological studies, and guidelines

Georg Griesinger et al. Hum Reprod Open. .

Abstract

Pre-conception counselling and management of expectations about chance of success of IVF/ICSI treatments is an integral part of fertility care. Registry data are usually used to inform patients about expected success rates of IVF/ICSI treatment, as these data should best represent real-world populations and clinical practice. In registries, the success rate of IVF/ICSI treatments is conventionally reported per treatment cycle or per embryo transfer and estimated from data for which several treatment attempts per subject have been pooled (e.g. repetitive IVF/ICSI attempts or repetitive attempts of cryotransfer). This, however, may underestimate the true mean chance of success per treatment attempt, because treatment attempts of women with a poor prognosis will usually be over-represented in a pool of treatment cycle data compared to treatment events of women with a good prognosis. Of note, this phenomenon is also a source of potential bias when comparing outcomes between fresh transfers and cryotransfers, since women can undergo a maximum of only one fresh transfer after each IVF/ICSI treatment, but potentially several cryotransfers. Herein, we use a trial dataset from 619 women, who underwent one cycle of ovarian stimulation and ICSI, a Day 5 fresh transfer and/or subsequent cryotransfers (follow-up of all cryotransfers up to 1 year after the start of stimulation), to exemplify the underestimation of the live birth rate, when not accounting for repeated transfers in the same woman. Using mixed-effect logistic regression modelling, we show that the mean live birth rate per transfer per woman in cryocycles is underestimated by the factor 0.69 (e.g. live birth rate per cryotransfer of 36% after adjustment versus 25% unadjusted). We conclude that the average chance of success of treatment cycles of women of a given age, treated in a given centre, etc., when conventionally calculated per cycle or per embryo transfer from a pool of treatment events, do not apply to an individual woman. We suggest that patients are, especially at the outset of treatment, systematically confronted with mean estimates of success per attempt that are too low. Live birth rates per transfer from datasets encompassing multiple transfers from single individuals could be more accurately reported using statistical models accounting for the correlation between cycle outcomes within women.

Keywords: IVF outcome; IVF registry; IVF success; embryo transfer; pregnancy rate.

PubMed Disclaimer

Conflict of interest statement

G.G. received no financial support for the research, authorship, and/or publication of this article. G.G. has, outside from this work, received honoraria and/or non-financial support (e.g. travel cost compensation) from Abbott, Ferring, Gedeon Richter, Guerbet, Merck, Organon, MSD, ObsEva, PregLem, ReprodWissen GmbH, Vifor and Cooper. P.L. is an employee of Ferring Pharmaceuticals.

Figures

Figure 1.
Figure 1.
Timepoints of all fresh transfers, cryotransfers, and live births in the RAINBOW trial. Digits represent the order of the transfers, with one being the first transfer (fresh transfer, or the first cryotransfer for subjects without fresh transfer). The women are sorted by time to first live birth, and shown as percent of all women, so that the live birth digits form a cumulative live birth rate versus time curve.
Figure 2.
Figure 2.
Live birth rate per transfer in the RAINBOW trial. The size of the bubbles indicates the number of women with fresh transfer or cryotransfer.
Figure 3.
Figure 3.
Live birth rate for different embryo qualities and for fresh and cryotransfers in the RAINBOW trial. The size of the bubbles (and the data labels) indicates the percentage of transfers performed with each embryo quality, with fresh and cryotransfers each summing up to 100%.

References

    1. Adamson GD, De Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O, Banker M, Dyer S.. International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011. Fertil Steril 2018;110:1067–1080. - PubMed
    1. Bartnitzky S, Blumenauer V, Czeromin U, Fehr D, Gnoth C, Grewe C, Krüssel J-S, Kupka MS, Tandler-Schneider A, Tauchert S.. D·I·R Annual 2020—the German IVF-Registry. J Reprod Med Endocrinol 2021;18:204–247.
    1. Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, Marca L, Lainas A, Le Clef G. et al. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open 2020;2020:hoaa009. - PMC - PubMed
    1. Bosdou JK, Venetis CA, Tarlatzis BC, Grimbizis GF, Kolibianakis EM.. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis. Hum Reprod 2019;34:491–505. - PubMed
    1. CDC. How to Access and Interpret Fertility Clinic Success Rates. Centers for Disease Control and Prevention, 2021. Available at: https://www.cdc.gov/art/reports/2019/how-to-access-interpret.html (May 2023, date last accessed).

LinkOut - more resources